This review discusses the expanding indications for direct oral anticoagulants, including their use around cardioversion, ablation procedures, and percutaneous coronary intervention.
May support expanded DOAC indications in select patients; leaves open need for randomized confirmation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gončarová et al. (2018) conducted a review in Atrial fibrillation. Direct oral anticoagulants (DOACs) vs. Vitamin K antagonists (VKA) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: